Document:

Form of Executive Officer Non-Qualified Stock Option Agreement

 EXHIBIT 10.32 
  
 FORM OF EXECUTIVE OFFICER 
 NON-QUALIFIED STOCK OPTION AGREEMENT 
  
 HOLOGIC, INC. 
 AMENDED AND RESTATED 1999 EQUITY INCENTIVE PLAN 
  
 Hologic, Inc. 
 35 Crosby Drive 
 Bedford, MA 01730 
  
 Notice of Grant of Stock Options 
 and Option Agreement 
  

			
	 Name:
	 	 _________________

	 Address:
	 	 _________________

	 Option Number:
	 	 _________________

	 Plan:
	 	 _________________

	 ID:
	 	 _________________

  
 Effective
                    , you have been granted a(n) Non-Qualified Stock Option to buy
             shares of Hologic, Inc. (the Company) stock at $             per share. 
  
 The total option price of the shares granted is
$            . 
  
 Shares in each period will become fully vested on the date shown. 
  

							
	Shares

	 	Vest Type

	 	Full Vest

	 	Expiration

	_______	 	On Vest Date	 	__________	 	__________
	_______	 	On Vest Date	 	__________	 	__________
	_______	 	On Vest Date	 	__________	 	__________
	_______	 	On Vest Date	 	__________	 	__________

  
 By your signature and the
Company’s signature below, you and the Company agree that these options are granted under and governed by the terms and conditions of the Company’s Stock Option Plan as amended and the Option Agreement, all of which are attached and made a
part of this document. 
  

			
	 Hologic, Inc.
	 	 Date

		
	 ____________________
	 	 
		
	 ____________________
	 	 Date

 HOLOGIC, INC. 
  
 NON-QUALIFIED STOCK OPTION AGREEMENT 
  
 Executive Officers 
  
 Non Qualified Stock Option Agreement (the “Option”) pursuant to the Hologic, Inc. amended and restated 1999 Equity Incentive Plan, as it may be
amended from time to time (the “Plan”). 
  
 W I T N E
S S E T H: 
  
 WHEREAS, the Corporation desires to grant the
Optionee an option (the “Option”) to purchase Common Stock, $.01 par value of the Corporation (the “Stock”); 
  
 WHEREAS, the Corporation and the Optionee desire to enter into an agreement whereby the Corporation will grant the Optionee an option to purchase shares
of the Common Stock, $.01 par value, of the Corporation (the “Stock”); and 
  
 WHEREAS, this Option is intended to qualify as a “Non-Qualified Stock Option”, which is a stock option which does not qualify as an incentive stock option under Section 422 of the Internal Revenue Code of
1986, as amended (the “Code”). 
  
 NOW THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Corporation and the Optionee agree as follows: 
  
 1. Grant of Option. 
  
 Pursuant to the terms and conditions of this Option, the Corporation hereby grants to the Optionee an Option to purchase, as provided in the Notice of
Grant of Stock Options shares of Stock (the “Option Shares”). 
  
 2. Purchase Price. 
  
 The price at which the
Option Shares may be purchased shall be the price set forth in the Notice of Grant of Stock Options (the “Option Exercise Price”). This price is not less than the Fair Market Value of the Stock on the date of this Option. 
  
 3. Exercise of Option. 
  
 Subject to the provisions of Section 4 and the right of the Corporation to
accelerate the date upon which any or all of this Option becomes exercisable, the Optionee shall be entitled to exercise this Option with respect to the percentage of the Option Shares provided in the Notice of Grant of Stock Options.
Notwithstanding the foregoing, in the event that the Employee ceases to be employed by the Corporation, a Parent, or a Subsidiary as a result of the death or Permanent Disability of the Employee or in the event of a Change in Control of the
Corporation, notwithstanding any provisions of the Option or the Notice of Grant of Stock Options with regard to the vesting of the Option in installments, the Option shall become immediately exercisable as to all of the Option Shares. For purposes
hereof a Change in Control of the Corporation shall mean: 
  
 a)
The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) of beneficial ownership (within the meaning of Rule 13d-3
promulgated under the Exchange Act) of 20% or more of the then outstanding shares of common stock of the Corporation (the “Outstanding Corporation Common Stock”); provided, however, that any acquisition by the Corporation or its
subsidiaries, or any employee benefit plan (or related trust) of the Corporation or its subsidiaries of 20% or more of Outstanding Corporation Common Stock shall not constitute a Change in Control; and provided, further, that any acquisition by a
corporation with respect to which, following such acquisition, more than 50% of the then outstanding shares of common stock of such corporation, is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and
entities who were the beneficial owners of the Outstanding Corporation Common Stock immediately prior to such acquisition in substantially the same proportion as their ownership, immediately prior to such acquisition, of the Outstanding Corporation
Common Stock, shall not constitute a Change in Control; or 

 b) Any transaction which results in the Continuing Directors (as defined in the Certificate of
Incorporation of the Corporation) constituting less than a majority of the Board of Directors of the Corporation; or 
  
 c) Approval by the stockholders of the Corporation of (i) a reorganization, merger or consolidation, in each case, with respect to which all or
substantially all of the individuals and entities who were the beneficial owners of the Outstanding Corporation Common Stock immediately prior to such reorganization, merger or consolidation do not, following such reorganization, merger or
consolidation, beneficially own, directly or indirectly, more than 50% of the then outstanding shares of common stock of the corporation resulting from such reorganization, merger or consolidation, (ii) a complete liquidation or dissolution of the
Corporation or (iii) the sale or other disposition of all or substantially all of the assets of the Corporation, excluding a sale or other disposition of assets to a subsidiary of the Corporation. 
  
 Notwithstanding any provision in this Option to the contrary, if an event
that would, but for this paragraph, constitute a Change of Control results from or arises out of a purchase or other acquisition of the Corporation, directly or indirectly, by a corporation or other entity in which the Optionee has a greater than
ten percent (10%) direct or indirect equity interest, such event shall not constitute a Change of Control. 
  
 Notwithstanding any provision of this Option to the contrary, in no event may this Option be exercised after ten years from the date of this Option (the
“Expiration Date”). 
  
 4. Termination of
Employment. 
  
 If the Optionee ceases to be employed by the
Corporation, a Parent, or a Subsidiary (a “Termination”), then this Option may be exercised as to all shares with respect to which Optionee could exercise this Option on the date of Termination, and which shares have not been previously
purchased, until the earlier of the Expiration Date, or: 
  

	 	(i)	in the case of termination by reason of death or Permanent Disability, one year after termination of employment; and 

  

	 	(ii)	in the case of termination by reason of retirement at age 65, or such other age as the Committee may determine, three months after the termination of employment; and

	 	(iii)	in all other cases, ninety days after the termination of employment; or 

  
 (iv) such other date as determined by the Compensation Committee. 
  

Notwithstanding the foregoing, in the case of Termination for cause, the ability to exercise this option may be terminated on such earlier date as the Corporation may
specify, and such date may be set so as to prevent the Optionee from further exercising any portion of this Option. 
  
 5. Nontransferability; Persons Able to Exercise. 
  
 The Option may not be transferred other than by will or the laws of descent and distribution. During the life of the Optionee, only the Optionee may
exercise this Option. If the Optionee dies while still employed by the Corporation, or the periods specified in Section 4, this Option may be exercised by his executors, administrators, legatees or distributees, provided that such person or persons
comply with the provisions of this Option applicable to the Optionee. 
  
 6. Method of Exercising Option. 
  
 The Option
may be exercised, in whole or in part, by written notice to the Corporation, containing an executed Notice of Exercise in the form of Attachment A, provided that the Corporation, in its discretion, may modify or augment these requirements as
provided in Section 9 of this Option, or where appropriate because a person other than the Optionee is exercising the Option pursuant to Section 5. The written notice specified in this Section must be accompanied by payment of the Option Exercise
Price for the shares being purchased. Payment shall be made in cash, unless the Corporation, in its sole discretion, authorizes payment to be made in shares of the Corporation or a combination of such shares and cash. As soon as practical after
receipt of this notice and payment, the Corporation shall deliver a certificate or certificates representing the purchased shares registered in the name of the person or persons exercising this Option. In the event this Option is exercised by any
person other than the Optionee, the notice shall be accompanied by appropriate proof of the right of such person to exercise this Option. All shares purchased upon the exercise of this Option and payment of the full Option Exercise Price will be
fully paid and nonassessable. 
  
 7. Stock Adjustments.

  
 If there shall be any change in the Stock through merger,
consolidation, reorganization, recapitalization, or other change in the corporate structure of the Corporation, appropriate adjustments in the total number and kind of shares subject to this Option, consistent with the requirements of the Code to
insure that this Option will be a Non-Qualified Stock Option, shall be made by the Corporation. 
  
 8. No Rights Other Than Those Expressly Created. 
  
 Neither this Option nor any action taken hereunder shall be construed as (i) giving the Optionee any right to be retained in the employ of, or continue to
be affiliated with, the Corporation, (ii) giving the Optionee any equity or interest of any kind in any assets of the Corporation, or (iii) creating a trust of any kind or a fiduciary relationship of any kind between the Optionee and the
Corporation. As to any claim for any unpaid amounts under this Option, any person having a claim for payments shall be unsecured creditor. The Optionee shall not have any of the rights of a stockholder with respect to any Option Shares until such
time as this Option has been exercised and Option Shares have been issued. 

 9. Compliance with Laws. 
  
 (a) Withholding of Taxes. Pursuant to applicable federal, state, local or foreign laws, the Corporation may be
required to collect or withhold income or other taxes from Optionee upon the grant of this Option, the exercise of this Option, or at some other time. The Corporation may require, as a condition to the exercise of this Option, or demand, at such
other time as it may consider appropriate, that the Optionee pay the Corporation the amount of any taxes which the Corporation may determine is required to be collected or withheld, and the Optionee shall comply with the requirement or demand of the
Corporation. 
  
 (b) Securities Law Compliance. Upon
exercise (or partial exercise) of this Option, the Optionee shall make such representations and furnish such information as may, in the opinion of counsel for the Corporation, be appropriate to permit the Corporation to issue or transfer the Option
Shares in compliance with the provisions of applicable federal or state securities laws. The Corporation, in its discretion, may postpone the issuance and delivery of Option Shares upon any exercise of this Option until completion of such
registration or other qualification of such shares under any federal or state laws, or stock exchange listing, as the Corporation may consider appropriate. In addition, the Corporation may require that prior to the issuance or transfer of Option
Shares upon exercise of this Option, the Optionee enter into a written agreement to comply with any restrictions on subsequent disposition that the Corporation deems necessary or advisable under any applicable federal and state securities laws.
Certificates of Stock issued hereunder may be legended to reflect such restrictions. 
  
 (c) General. No Option Shares shall be issued upon exercise of this Option unless and until the Corporation is satisfied, in its sole discretion, that there has been compliance with all legal requirements
applicable to the issuance of such Option Shares. 
  
 10.
Miscellaneous. 
  
 (a) Non-Qualified Option. The
Option hereby granted is not intended to be an “incentive stock option” as that term is defined in Section 422 of the Internal Revenue Code. 
  
 (b) Discretion of the Committee. Unless otherwise explicitly provided herein, the Board of Directors of the Corporation, or authorized committee
thereof, shall make all determinations required to be made hereunder, including determinations required to be made by the Corporation, and shall interpret all provisions of this Option, as it deems necessary or desirable, in its sole and unfettered
discretion. Such determinations and interpretations shall be binding and conclusive to the Corporation and the Optionee. 
  
 (c) Reservation of Shares. During the term of this Option, the Corporation shall at all times reserve and keep available shares of Stock sufficient
to satisfy the requirements of this Option. 
  
 (d)
Amendment. This Option may only be modified or amended by a writing signed by both parties. 

 (e) Notices. Any notices required to be given under this Option shall be sufficient if in writing
and if sent by certified mail, return receipt requested, and addressed as follows: 
  
 if to the Corporation: 
  
 Hologic, Inc. 
 35 Crosby Dr. 
 Bedford, MA 01730 
 Attention: Treasurer 
  
 if to the Optionee: 

 
 As stated on the Notice of Grant of Stock Option

  
 or to such other address as either party may designate under the provisions
hereof. 
  
 (f) Successors and Assigns. The rights and
obligations of the Corporation under this Option shall inure to the benefit of and be binding upon the successors and assigns of the Corporation. 
  
 (g) Applicable Law. All rights and obligations under this Option shall be governed by the laws of the Commonwealth of Massachusetts. 
  
 (h) Paragraph Headings. The paragraph headings used in this Option are
for convenience or reference, and are not to be construed as part of this Option.Amended and Restated Shareholder Agreement

 Exhibit 10.1 
  
 AMENDED AND RESTATED SHAREHOLDERS AGREEMENT 
  
 AGREEMENT made as of July 15, 2004, by and among Da-Lite Screen Company, Inc., an Indiana corporation (the
“Company”) and the other persons listed on the signature pages hereto (such persons are sometimes herein referred to individually as “Shareholder” and collectively as “Shareholders”). 
  
 W I T N E S S E T H: 
  
 WHEREAS, certain of the Shareholders previously entered into a Shareholders
Agreement dated as of September 8, 1989 (as amended, the “Original Agreement”) to promote the harmonious management of the Company; 
  
 WHEREAS, the Board of Directors of the Company (the “Board”) and the Shareholders determined it to be in the best interests of the Company and
its shareholders to qualify the Company as a Subchapter S Corporation (as defined below); 
  
 WHEREAS, under the Internal Revenue Code of 1986, as amended (the “Code”), certain restrictions apply as to the type and number of shareholders that a Subchapter S Corporation may have; 
  
 WHEREAS, in order to establish and preserve the Company’s Subchapter S
Corporation status, the Original Agreement was being amended and restated as of September 19, 1997 to provide for certain restrictions on the transfer of Shares (such amended agreement being referred to as the “Amended Agreement”); and

  
 WHEREAS, the Board deems it desirable to make amendments to
the Amended Agreement; 
  
 NOW, THEREFORE, it is hereby agreed
that the Amended Agreement is amended and restated in its entirety as set forth herein. 
  
 1. Certain Definitions. 
  
 1.1 “2.5% Transaction.” The term “2.5% Transaction” shall mean a transaction in which a Shareholder or Additional Shareholder Transfers two and one-half percent (2.5%) or more of the Total Shares
Outstanding of the Company. 
  
 1.2 “Act.”
The term “Act shall mean the United States Securities Act of 1933, as amended. 
  
 1.3 “Additional Shareholder.” The term “Additional Shareholder” shall mean a Person, other than a Shareholder, who beneficially owns Shares other than Shares issued in a Public
Offering. 

 1.4 “Affiliate.” The term “Affiliate” shall mean with respect to any
Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such Person. 
  
 1.5 “Alternative Purchase Price Per Share.” The term “Alternative Purchase Price Per
Share” shall mean, with respect to Shares purchased from a Shareholder or Additional Shareholder in connection with a Transfer that constitutes a 2.5% Transaction, an amount determined in good faith by the Board as the value per Share as of the
date on which the purchase is deemed to be effective based on an appraisal made by an appraiser selected by the Board (which selection shall be subject to the approval of such transferring Shareholder or Additional Shareholder, which approval shall
not be unreasonably withheld) of the valuation of the Company as of such date based on financial statements of the Company for the four most recent calendar quarters. In computing the Alternative Purchase Price Per Share, the Board shall consider,
in addition to outstanding Shares, the dilution effect of options, warrants or other rights to acquire common stock of the Company and will not impute any discount or premium based on the percentage of the Company represented by the Shares being
purchased or the illiquidity of any such Shares. 
  
 1.6
“Alternative Sales Transaction.” The term “Alternative Sales Transaction” shall have the meaning set forth in Section 7(b) of this Agreement. 
  
 1.7 “Approved Shareholder.” The term “Approved Shareholder” shall mean an Additional
Shareholder who is granted first refusal rights pursuant to Section 6 of this Agreement. 
  
 1.8 “Beneficially Owns.” The term “Beneficially Owns” shall mean, with respect to any Shares of any Person, all Shares in respect of which such Person, directly or indirectly, whether
by contract, arrangement, relationship or otherwise, exercises (i) voting power, including the power to vote or to direct the voting of any such Shares or (ii) investment power, including the power to dispose of or to direct the disposition of any
such Shares, and shall include specifically, without limitation, any Shares held in an individual retirement account or other self-directed employee benefit plan in respect of which such Person exercises the exclusive power to direct investments and
any shares which may be acquired through the exercise of options, warrants and other convertible securities. 
  
 1.9 “Board.” The term “Board” shall have the meaning set forth in the recitals of this Agreement. 
  
 1.10 “Change in Status.” The term “Change in
Status” shall mean any event or change in status of a Shareholder, Additional Shareholder or a related party that would cause the Subchapter S Corporation status of the Company to terminate or the number of shareholders of the Company (as
determined under Section 1361 of the Code) to increase. 
  
 1.11 “Code.” The term “Code” shall have the meaning set forth in the recitals of this Agreement. 
  
 1.12 “Company.” The term “Company” shall have the meaning set forth in the first paragraph of this Agreement.

  

 2 

 1.13 “Control.” The term “Control” shall mean the ability to direct the
management or policies of a Person. 
  
 1.14 “Funded
Indebtedness.” The term “Funded Indebtedness” shall mean (i) the principal of (and premium, if any) and interest on, and all expenses, fees, reimbursements, indemnities or other amounts payable with respect to, (a) all
indebtedness of the Company, whether outstanding on the date of this Agreement or thereafter created, incurred or assumed (including, without limitation, the Company’s 9 1/2% Senior Notes due 2011), which is (1) for money borrowed or (2) evidenced by a note or similar instrument given in connection with the acquisition of any businesses, properties
or assets of any kind (other than trade payables incurred in the ordinary course of business), (b) obligations of the Company as lessee under leases required to be capitalized on the balance sheet of the lessee under generally accepted accounting
principles and (c) amendments, renewals, extensions, modifications, increases and refunding of any such indebtedness, borrowings or other amounts payable, (ii) any obligations of the Company in respect of any interest rate or currency swap, exchange
or future agreement, or similar agreements or derivative contracts, and (iii) all amounts payable by, and all payment obligations of, the Company (and interest in connection therewith), whether in existence on the date of this Agreement or
thereafter created, incurred or assumed, either (a) to reimburse or otherwise compensate or assure banks or others with respect to letters of credit or performance bonds for payments made under such letters of credit or performance bonds or (b) to
provide cash collateral to any Person that shall have issued a letter of credit or performance bond. 
  
 1.15 “Non-Selling Shareholders.” The term “Non-Selling Shareholders” shall have the meaning set forth in Section 4.1 of
this Agreement. 
  
 1.16 “Non-Triggering
Person.” The term “Non-Triggering Person” shall have the meaning set forth in Section 7(c) of this Agreement. 
  
 1.17 “Non-Triggering Shareholders.” The term “Non-Triggering Shareholders” shall mean those Shareholders, Approved
Shareholders and their Permitted Transferees of the Company who are not Triggering Shareholders. 
  
 1.18 “Non-Triggering Shareholders’ Representatives.” The term “Non-Triggering Shareholders’ Representatives”
shall have the meaning set forth in Section 7(c) of this Agreement. 
  
 1.19 “Offered Shares.” The term “Offered Shares” shall have the meaning set forth in Section 4.1 of this Agreement. 
  

1.20 “Operating Cash Flow.” The term “Operating Cash Flow” shall mean earnings of the Company before interest, taxes,
depreciation, amortization and impairment loss but eliminating the effect of any extraordinary or unusual items, in each case, as determined in good faith by the Board. 
  
 1.21 “Original Agreement.” The term “Original Agreement” shall have the meaning set forth
in the recitals of this Agreement. 
  

 3 

 1.22 “Permitted Transfer.” The term “Permitted Transfer” shall mean any
Transfer of Shares (i) by gift or other distribution by (x) any Shareholder who is a natural Person to his or her spouse or descendants (whether by blood, adoption or marriage) or to trustees of a trust for the exclusive benefit of such Shareholder,
his or her spouse or such descendants (any such spouse, descendant or trustee being referred to as a “Shareholder-Related Person”) of such Shareholder, or (y) a Shareholder-Related Person to such Shareholder or to another
Shareholder-Related Person of such Shareholder provided, however, that, unless otherwise consented to by the Board or 66 2/3% of the Shareholders (other than the transferring Shareholder or Shareholder-Related Person, or any Shareholder-Related Persons of such Transferring Shareholder or transferring Shareholder-Related Person), such Shareholder
or transferring Shareholder-Related Person retains voting control of the Shares so transferred and exclusive power to exercise all rights under this Agreement; (ii) between any Shareholder who is a natural Person and such Shareholder’s guardian
or conservator; (iii) upon or after the death of a Shareholder who is a natural Person, by will, intestacy laws, or the laws of survivorship to such Shareholder’s legal representative, heirs or legatees; (iv) by a Shareholder to the Company;
(v) pursuant to a Public Offering of such Shares; (vi) to the extent not prohibited by any pledge agreement required under Section 12 hereof, by way of pledge to a bank or recognized financial institution (provided that any foreclosure or other
action taken against the pledge by the pledgee shall be subject to the provisions of Section 6 hereof); (vii) by way of pledge to any Person for the benefit of the Company pursuant to any pledge agreement contemplated by the credit agreement
referred to in Section 1.14 hereof or a pledge agreement required under Section 12 hereof (including without limitation, any sale or other Transfer pursuant to the exercise of any right or remedy under such pledge agreement); (viii) to an entity
provided that the Shareholder is, and at all times remains, the majority owner of all of the issued and outstanding voting equity of such entity or by such entity to such Shareholder; (ix) to an entity that is, or is directly or indirectly
controlled by, the Person controlling such Shareholder, provided that such Permitted Transferee has not been formed solely for the purpose of engaging in a Permitted Transfer (provided, however, that any event which severs the Control
relationship shall be deemed to be a Transfer subject to the restrictions provided in this Agreement); (x) to the equity owners of a Shareholder which is an entity upon the dissolution of such entity; (xi) in the event a Shareholder is or becomes,
or is or becomes controlled by, an “investment company” subject to the provisions of the Investment Company Act of 1940, a transfer which is necessary to effect compliance with such act or the rules and regulations thereunder; and (xii)
from the custodian or trustee of an individual retirement account or other self directed employee benefit plan to the beneficiary of such account or plan or to the custodian or trustee of another individual retirement account or self directed
employee benefit plan; provided, however, that in the case of any such Transfer (other than a transfer pursuant to clause (vii)), the transferred Shares shall remain subject to the provisions of this Agreement in the hands of the
Permitted Transferee, the Permitted Transferee shall execute an agreement, in substantially the form of Exhibit 1 hereto, agreeing to be bound by the terms and conditions of this Agreement and the Shareholder shall submit copies of all
pertinent documentation at least five days prior to completion of the transaction to demonstrate that the Transfer is a Permitted Transfer; provided further, that any such Transfer (other than a transfer pursuant to clause (vii)), will
not be deemed to be a “Permitted Transfer” (a) to the extent prohibited by Section 3(a) of this Agreement or (b) to the extent that compliance with the requirements of Section 3(b) of this Agreement have not been met. 
  

 4 

 1.23 “Permitted Transferee.” The term “Permitted Transferee” shall mean
a Person holding Shares pursuant to a Permitted Transfer. 
  
 1.24 “Person.” The term “Person” shall mean any individual, corporation, partnership, limited liability company, joint venture, association, trust, unincorporated organization or governmental entity and any
agency or political subdivision thereof. 
  
 1.25
“Prime Rate.” The term “Prime Rate” shall mean the prime rate as published from time to time in The Wall Street Journal. 
  

1.26 “Public Offering.” The term “Public Offering” shall mean the consummation of a sale or series of sales to the
public of Shares pursuant to one or more effective registration statements under the Act, with aggregate net proceeds to the Company and other sellers of not less than $25,000,000. 
  
 1.27 “Purchase Price Per Share.” The term “Purchase Price Per Share” shall mean, with
respect to Shares purchased from a Shareholder or Additional Shareholder in connection with a Transfer that does not constitute a 2.5% Transaction, an amount determined in good faith by the Board as the value per Share as of the date on which the
purchase is deemed to be effective based on the Total Company Valuation as of such date. In computing the Purchase Price Per Share, the Board shall consider, in addition to outstanding Shares, the dilution effect of options, warrants or other rights
to acquire shares of common stock and will not impute any discount or premium based on the percentage of the Company represented by the Shares being purchased or illiquidity of any such Shares. 
  
 1.28 “Sales Price.” The term “Sales Price”
shall have the meaning set forth in Section 7(a) of this Agreement. 
  
 1.29 “Sales Transaction.” The term “Sales Transaction” shall mean a transaction in which the Company sells or otherwise directly or indirectly transfers any of its capital stock or all or substantially all
of its assets to any Person or merges with or into any Person. 
  
 1.30 “Sales Transaction Notice.” The term “Sales Transaction Notice” shall have the meaning set forth in Section 7(a) of this Agreement. 
  
 1.31 “Selling Shareholder.” The term “Selling Shareholder” shall have the meaning set
forth in Section 4.1 of this Agreement. 
  
 1.32
“Senior Indebtedness.” The term “Senior Indebtedness” shall mean all Funded Indebtedness unless, in each case, by the terms of the instrument creating or evidencing the indebtedness it is provided that such
indebtedness is not superior in right to the obligations described in Section 4.1 of this Agreement. 
  
 1.33 “Serious Misconduct.” The term “Serious Misconduct” shall mean embezzlement or misappropriation of partnership or
corporation funds, the commission of a felony or other acts of dishonesty, fraud or deceit, a material breach of this Agreement, habitual or willful neglect of duties, a serious breach of fiduciary duty or a significant violation of any other
contractual, statutory or common law duty to the Company, any Affiliate of the Company, the Shareholders or the Additional Shareholders. 
  

 5 

 1.34 “Shareholder(s).” The term “Shareholder(s)” shall have the meaning
set forth in the first paragraph of this Agreement. 
  
 1.35
“Shares.” The term “Shares shall mean any common stock of the Company issued and outstanding from time to time. 
  
 1.36 “Subchapter S Corporation.” The term “Subchapter S Corporation” shall mean a corporation that qualifies as an
“S Corporation” for purposes of Subchapter S of the Code. 
  
 1.37 “Total and Permanent Incapacity.” The term “Total and Permanent Incapacity” shall mean the existence of any physical or mental condition with respect to a Director of the Company which is expected to
continue for 180 days or more and which renders such Director incapable of performing (as confirmed by competent medical evidence) any substantial portion of the duties properly assigned to such Director. 
  
 1.38 “Total Company Valuation.” The term “Total
Company Valuation” as of any date shall mean six (6) times the Company’s Operating Cash Flow for the four most recent calendar quarters for which financial statements of the Company are available reduced by Funded Indebtedness and the
value of the minority interest in subsidiaries (using the same six (6) times Operating Cash Flow methodology of any such subsidiaries as is used in this definition for the Company as a whole) as of the end of such four calendar quarters and adjusted
upward or downward for any positive or negative cash balances as of the valuation date. 
  
 1.39 “Total Shares Outstanding.” The term “Total Shares Outstanding” shall mean the number of shares of common stock of the Company issued and outstanding from time to time.

  
 1.40 “Transfer.” The term
“Transfer” shall mean any transfer, sale, assignment, exchange, gift, bequest, hypothecation, pledge, grant of security interest or lien, placement in trust (voting or otherwise), transfer by operation of law (other than a merger or
consolidation of the Company) or any other encumbrance or disposition, direct or indirect and whether or not voluntary, of any Shares. A “Transfer” shall include, without limitation, any transaction or event, whether or not voluntary, that
creates a form of joint ownership in the Shares between the transferor and one or more persons (whether or not that other person is the spouse of the transferor) or any transaction that creates or grants an option, warrant, or right to obtain an
interest in the Shares. 
  
 1.41 “Triggering
Shareholders.” The term “Triggering Shareholders” shall have the meaning set forth in Section 7(a) of this Agreement.. 
  
 2. General Prohibitions of Transfer. (a) Except for Permitted Transfers, no Shareholder or Additional Shareholder shall Transfer any Shares
beneficially owned by such Shareholder or Additional Shareholder other than upon compliance in all respects with the procedures set forth in this Agreement. Notwithstanding any provision of this Agreement, no Shareholder or Additional Shareholder
shall Transfer any Shares in violation of the Act and any applicable state or foreign securities laws. 
  

 6 

 (b) The Company, by execution of this Agreement, agrees that it will not cause or permit the transfer of
any Shares to be made on its books except in accordance with the terms of this Agreement. 
  
 (c) Any purported Transfer or acquisition of Shares in violation of this Section 2 shall be null and void ab initio. The purported transferee shall have no interest in any of the Shares purported to be transferred,
shall not be deemed an Additional Shareholder of the Company, and shall not be entitled to receive a new stock certificate for Shares or any dividends or other distributions on or with respect to the Shares. Each Shareholder and Additional
Shareholder agrees that any such Transfer or acquisition may and should be enjoined. 
  
 3. Transfer Restrictions Relating to the Company’s Status as a Subchapter S Corporation; Change in Status. (a) Except as may result from a Transfer described in clause (vii) of Section 1.22 hereof,
no Shareholder or Additional Shareholder may Transfer and no person may acquire, the legal, economic or beneficial ownership of, or any other interest in, any Share if such Transfer or acquisition would cause the Subchapter S Corporation status of
the Company to terminate. Specifically, except for a Transfer described in clause (vii) of Section 1.22 hereof, no Transfer may be made to, and no acquisition may be made by, any person that is not eligible to be a shareholder of a Subchapter S
Corporation under the provisions of the Code as in effect at the time of the purported Transfer (presently including non-resident aliens and any person other than an individual, an estate or certain limited types of trusts). In addition, no
Shareholder or Additional Shareholder may Transfer (except for a Transfer described in clause (vii) of Section 1.22 hereof) the legal, economic or beneficial ownership of any Share if such Transfer would cause the number of shareholders of the
Company (as determined under Section 1361 of the Code) to increase without the written consent of the Board, which consent may be withheld in the discretion of the Board. 
  
 (b) No Transfer of Shares (except for a Transfer described in clause (vii) of Section 1.22 hereof) shall be permitted, and
no purported Transfer shall be effective, unless and until (i) the Shareholder or Additional Shareholder desiring to Transfer Shares shall have provided the Company, within a reasonable time prior to the proposed Transfer, with a statement regarding
the identity of the proposed transferee sufficient to satisfy the Company that the transferee is a person that is eligible to be a shareholder of a Subchapter S Corporation and the Transfer will not result in an increase in the number of
shareholders of the Company (except to the extent such increase has been consented to by the Board as provided in Section 3(a) hereof), (ii) if the proposed transferee is a trust, (A) the Company has received, within a reasonable time prior to the
proposed Transfer, copies of all relevant trust documents, (B) the Company has, at its option and at the sole expense of the Shareholder or Additional Shareholder, obtained a private letter ruling from the Internal Revenue Service or an opinion of
the Company’s counsel or of the Shareholder’s or Additional Shareholder’s counsel acceptable to the Company, providing, in form and substance acceptable to the Company, that the Transfer to the trust will not adversely affect the
Company or any of its shareholders under Subchapter S of the Code or, except to the extent consented to by the Board, increase the number of shareholders of the Company (as determined under Section 1361 of the Code) and (C) any persons treated as
shareholders of the 
  

 7 

 Company (as determined under Section 1361 of the Code) agree to be bound by the provisions of this Agreement as if they
were a Shareholder or an Additional Shareholder and enter into such agreements and make such representations or warranties as the Company shall request in connection therewith, (iii) the Company has provided written notice to the Shareholder or
Additional Shareholder and the transferee that the requirements of clause (i) or (ii) above have been satisfactorily met, and (iv) the transferee has executed an agreement, in substantially the form of Exhibit 1 hereto, agreeing to be bound
by the terms and conditions of this Agreement. 
  
 (c) Any
purported Transfer or acquisition of Shares in violation of this Section 3 shall be null and void ab initio. The purported transferee shall have no interest in any of the Shares purported to be transferred, shall not be deemed an Additional
Shareholder of the Company, and shall not be entitled to receive a new stock certificate for Shares or any dividends or other distributions on or with respect to the Shares. Each Shareholder and Additional Shareholder agrees that any such Transfer
or acquisition may and should be enjoined. 
  
 (d) If a purported
Transfer occurs in violation of this Section 3, then the Shares purported to be transferred shall, at the Company’s option, be deemed to be redeemed immediately before the occurrence of the purported Transfer at the price and in the manner
provided for in Section 3(f) hereof. 
  
 (e) No Shareholder or
Additional Shareholder may cause or effect a Change in Status. If, in violation of the preceding sentence, a Change in Status occurs, then the Shares owned by the Shareholder or Additional Shareholder, shall at the Company’s option, be deemed
to be redeemed immediately before the occurrence of the Change in Status at the price and in the manner provided for in Section 3(f) hereof. 
  
 (f) If the Company exercises its option to purchase the Shares pursuant to Section 3(d) or 3(e) hereof, the amount per share paid therefor shall be the
Purchase Price Per Share in the case of a purported Transfer that does not constitute a 2.5% Transaction or the Alternative Purchase Price Per Share, in the case of a purported Transfer that constitutes a 2.5% Transaction, which amount shall be
payable in cash, certified check or wire transfer at the date specified in the notice of exercise (which shall be not more than 45 days after the date of such notice), or, if such payment would conflict with any covenants in any credit or loan
agreements of the Company, in semi-annual installments over four years with interest accruing at the Prime Rate from time to time plus one-percent (1%) payable semi-annually. The Company’s obligation to pay any deferred payment of the Purchase
Price Per Share or the Alternative Purchase Price Per Share, as the case may be, shall be represented by a subordinated note. Such note shall be secured by the Shares being purchased by the Company. Such note shall be subordinated to all Senior
Indebtedness and no payments of principal or interest shall be made on any part of such note if there exists a payment default on any Senior Indebtedness or a nonpayment default on any Senior Indebtedness (unless such nonpayment default has
continued for more than 270 days). The form and content of such note and security agreement shall be substantially consistent herewith and otherwise as determined by the Board at the time the Shares are purchased by the Company. The Company may
assign its option to a designee provided that, if the Purchase Price Per Share or the Alternative Purchase Price Per Share, as the case may be, is not being paid entirely in cash, the Company shall guarantee the assignee’s obligations.

  

 8 

 (g) Each Shareholder and Additional Shareholder acknowledges that a termination of the Company’s
status as a Subchapter S Corporation by reason of a Transfer of Shares in violation of this Section 3 or a Change in Status may cause material adverse tax effects to the other Shareholders and Additional Shareholders. For this reason, any
Shareholder or Additional Shareholder who contemplates a Transfer of Shares or a Change in Status agrees to advise the Company at least 30 days (or such shorter period as the Company may agree) in advance of any such Transfer or Change in Status, so
that the Company may take action to preserve its status as a Subchapter S Corporation. 
  
 (h) If the Company’s status as a Subchapter S Corporation is terminated inadvertently and the Company wishes to obtain a ruling under Section 1362(f) of the Code, each Shareholder and Additional Shareholder
agrees to make any adjustments required pursuant to Section 1362(f)(4) of the Code and approved by the Board. A Shareholder’s or Additional Shareholder’s obligation to make such adjustments shall continue after the Shareholder or
Additional Shareholder has ceased to own Shares in the Company and after this Agreement has terminated. 
  
 (i) Each Shareholder and Additional Shareholder agrees to take all actions necessary to enable and allow the Company to elect, and maintain an election,
to be treated as a Subchapter S Corporation under the Code, including, without limitation, consenting to the election pursuant to Section 1362 of the Code. 
  
 (j) This Section 3 no longer apply if the Board determines that the Company shall not elect to qualify, or continue to qualify, as a Subchapter S
Corporation. 
  
 (k) Each Shareholder and Additional Shareholder
who sells Shares to the Company pursuant to Section 3 hereof hereby represents and warrants to the Company or its designee that, as of the date of closing of such purchase by the Company: 
  
 (i) Such seller has full right, power and authority to sell,
assign, transfer and deliver the Shares to be sold by such seller; 
  
 (ii) The sale of the Shares by such seller will not result in a breach or violation of any of the terms or provisions of, or constitute a default under, any statute, any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument to which such seller is a party or by which such seller is bound, the charter, by-laws, partnership agreement, limited liability company agreement or other organizational document of such seller, or any
judgment or order of any court or governmental agency or body having jurisdiction over such seller or the property of such seller; 
  
 (iii) Such seller has good and valid title to the Shares being sold, free and clear of all liens, encumbrances, equities or claims (other
than liens created pursuant to Section 12 hereof); and, upon delivery of such Shares and payment therefor, good and valid title to such Shares, free and clear of all liens, encumbrances, equities or claims (other than liens created by the purchaser
thereof or pursuant to Section 12 hereof), will pass to the purchaser thereof; and 
  

 9 

 (iv) The sale of Shares will be in compliance with all applicable federal and state
securities laws (it being understood that the seller may base such representation on representations reasonably requested from the purchases or, failing the receipt of representations reasonably requested, reasonable assumptions with respect
thereto). 
  
 4. Rights of First Refusal Regarding Stock
Transfers. 
  
 4.1 Company’s Right of First
Refusal. Except for Permitted Transfers and transactions contemplated by Section 7 hereof, no Shareholder or Additional Shareholder will solicit or accept, or Transfer any Shares pursuant to, any offer other than a bona fide offer to
purchase such Shares solely for cash (subject to the ability to obtain certain consideration other than cash as provided in Section 4.5 hereof). Except for Permitted Transfers or transactions contemplated by Section 7 hereof, in the event that a
Shareholder or Additional Shareholder (the “Selling Shareholder”) shall desire to Transfer such Person’s Shares or any portion thereof (the “Offered Shares”) and shall be in receipt of a bona fide written offer
to purchase the Offered Shares for no consideration other than cash, subject to the restrictions on transfer in Sections 2 and 3 hereof and in addition to the requirements of Section 3(b) hereof, the following procedure shall apply. The Selling
Shareholder shall give to the Company, and the Company shall promptly thereafter give to each other Shareholder and Approved Shareholder (individually “Non-Selling Shareholder” and collectively “Non-Selling Shareholders”),
written notice containing the terms and conditions of the proposed sale, including, but not limited to, and where applicable: 
  
 (i) the number of Offered Shares; 
  
 (ii) the price per Share; 
  
 (iii) the name(s) of the proposed purchaser(s); and 
  
 (iv) a copy of the written offer signed by the prospective purchaser(s). 
  
 A written offer shall not be deemed bona fide unless the offer is for a
purchase for no consideration other than cash by a responsible party (as reasonably determined by the Board) and the Selling Shareholder has informed the prospective purchaser of the obligations of all Shareholders, Additional Shareholders and the
Company under this Agreement and the prospective purchaser has agreed to execute an agreement in substantially the form of Exhibit 1 hereto and to be bound by the terms and conditions of this Agreement. The Board is entitled to take such
steps as it reasonably may deem necessary to determine the validity and bona fide nature of the prospective purchaser’s offer and the responsibility of such party. 
  
 Until 30 days after such notice is given, the Company shall have the right, exercisable by giving notice to the Selling
Shareholder within such 30-day period, to purchase the Offered Shares or any portion thereof at the price offered by the prospective purchaser and specified in such notice either (1) in cash or by certified check or wire transfer immediately upon
the closing of the transaction or (2) if such payment would conflict with any covenants in any credit or loan agreements of the Company, in semi-annual installments over four years with 
  

 10 

 interest accruing at the Prime Rate from time to time plus one-percent (1%) payable semi-annually. The Company’s
obligation to pay any deferred payment of the purchase price shall be represented by a subordinated note. Such note shall be secured by the Offered Shares so purchased. Such note shall be subordinated to all Senior Indebtedness and no payments of
principal or interest shall be made on any part of such note if there exists a payment default on any Senior Indebtedness or any nonpayment default on any Senior Indebtedness (unless such nonpayment default has continued for more than 270 days). The
form and content of such note and security agreement shall be substantially consistent herewith and otherwise as determined by the Board at the time the Offered Shares are so purchased. The Company may assign its option to a designee provided that,
if the purchase price per share is not being paid entirely in cash, the Company shall guarantee the assignee’s obligations. 
  
 After giving notice under this Section 4.1, the Selling Shareholder shall refrain from participating as an officer, director or shareholder of the Company
in the Company’s decision whether to purchase any or all of the Offered Shares. 
  
 4.2 Non-Selling Shareholders’ Right to Purchase on Company’s Refusal. If the Company does not exercise its right to purchase all of the Offered Shares within the 30-day period specified above,
subject to Section 3 hereof, each Non-Selling Shareholder shall have the right to purchase for cash at the price offered by the prospective purchaser (i) such portion of the remaining Offered Shares as shall equal the number of Shares beneficially
owned by such Non-Selling Shareholder divided by the sum of such number plus the number of Shares beneficially owned by all other Non-Selling Shareholders and (ii) such number of Offered Shares determined pursuant to the allotment referred to in the
second succeeding sentence. A Non-Selling Shareholder may exercise its right to purchase any or all of the Offered Shares to which it is entitled by giving notice of the number of Offered Shares to be purchased by it to the Company within 15 days
after the expiration of the 30-day period referred to above and, if such notice is timely given, must purchase the full number so notified. If any Non-Selling Shareholder does not exercise its right to purchase the full amount of its portion of the
remaining Offered Shares, such Offered Shares not so purchased shall be allotted successively among the Non-Selling Shareholders desiring to purchase such Offered Shares, in proportion to the number of Shares beneficially owned by such Non-Selling
Shareholder relative to the sum of the number of Shares beneficially owned by all other Non-Selling Shareholders desiring to purchase such Offered Shares at the time of each successive allotment (after giving effect to acquisitions under prior
allotments), until either (a) all Offered Shares have been purchased or (b) each Non-Selling Shareholder has purchased and received the full number of Shares that it desires to purchase. 
  
 4.3 Closing. The closing of any purchase by the Company or Non-Selling Shareholder, as the case may be, of all
or any portion of any Offered Shares as provided in Sections 4.1 and 4.2 hereof shall take place on such date as is designated by the Company or Non-Selling Shareholder, as the case may be, in its or their notice to the Selling Shareholder of the
election to purchase such Offered Shares, provided that such closings must take place within 75 days of the Selling Shareholder’s notice pursuant to Section 4.1 hereof. At each such closing, the Selling Shareholder shall deliver to the Company
or Non-Selling Shareholder, as the case may be, any certificates representing the Offered Shares to be so purchased (properly endorsed for transfer and with any required stock transfer tax stamps attached, together with such other documentation as
the Company or Non-Selling Shareholder, as the case may be, shall reasonably request to evidence the Transfer of such Offered Shares) against payment therefor by the Company or the Non-Selling Shareholder, as the case may be. 
  

 11 

 4.4 Representations and Warranties of Selling Shareholder. Each Shareholder and Additional
Shareholder who is a Selling Shareholder pursuant to Section 4.1 or 4.2 hereof hereby makes the representations and warranties enumerated in Section 3(k) hereof to the Company, its designee or the Non-Selling Shareholder purchasing from such seller,
in each case as of the date of closing of such purchase. 
  
 4.5 Failure of Company and Non-Selling Shareholders to Purchase Offered Shares. An election by the Company and the Non-Selling Shareholders to exercise their rights under this Section 4 shall be ineffective if, in the
aggregate, they do not elect to purchase at least 50% of the Offered Shares. If less than all of the Offered Shares are purchased by the Company or the Non-Selling Shareholders within the 75-day period granted for such purchases, then the remaining
Offered Shares may be Transferred free from the restrictions of this Section 4; provided, however, that the Offered Shares must be Transferred within 30 days of the expiration of the 75-day period to the person or persons named in, and
under the terms and conditions (other than price, which may be increased provided no less cash is received) of, the bona fide offer described in the notice to the Company and Non-Selling Shareholders; and provided
further, that such Transfer is made subject to the provisions of Section 6 hereof requiring Additional Shareholders to become bound by the terms and conditions of this Agreement. If the Selling Shareholder shall not Transfer the Offered
Shares within said 30-day period, he shall not thereafter Transfer any Shares without again complying with the requirements of Section 3(b) hereof and giving written notice and offering such Shares to the Non-Selling Shareholders pursuant to this
Section 4. 
  
 4.6 Conflicts. In the event a sale of
Shares pursuant to this Section 4 also triggers the provisions set forth in Section 7 hereof, Section 7 shall control. 
  
 5. Board of Directors. 
  
 5.1 Formation and Composition of Board of Directors. (a) As part of the consideration for the transactions contemplated hereby, each
Shareholder and Additional Shareholder agrees that he will take and will cause to be taken at all times all necessary action (corporate and otherwise), including the voting of equity interests, to elect as the Board a slate comprised solely of the
following individuals: James S. Cownie, James M. Hoak, Wayne Kern, David J. Lundquist, David N. Walthall and Richard E. Lundin. The Board has full power and authority to remove any Director in the event such Director engages in any way in Serious
Misconduct. 
  
 5.2 Resignation of Directors. A
Director who (i) reduces the number of Shares Beneficially Owned by him through Transfers other than Permitted Transfers (except that Permitted Transfers pursuant to subsections (ii), (iv) and (v) of Section 1.22 hereof shall be deemed a reduction
in the amount of Shares Beneficially Owned for purposes of this Section 5.2) to a level at, or below, 33 1/3% of
the amount of Shares Beneficially Owned by such Director as of the date hereof (as adjusted for any and all stock splits, stock dividends or recapitalization) or (ii) is also an employee of the Company, terminates his employment with the Company for
any 
  

 12 

 reason, hereby agrees to resign as Director of the Company. In the event such Director refuses to resign from the Board,
the Board shall immediately call a special meeting of shareholders and all Shareholders and Additional Shareholders shall vote to remove such Director from the Board. 
  
 5.3 Replacement of Directors Other than by Election. In the event of the resignation, removal, death, Total
and Permanent Incapacity, or reduction in the amount of Shares Beneficially Owned (as described in Section 5.2 hereof) of a Director, a majority of the remaining Directors will then select a replacement Director (which replacement Director will then
be deemed to be included in the slate described in Section 5.1 hereof). 
  
 5.4 Action with Respect to Options. A member of the Board who is, or is affiliated with, the Shareholder or Additional Shareholder whose Shares are subject to any option of the Company under this Agreement shall not
participate in any decision of the Board relating to the exercise or non-exercise of any such option or the determination of the Purchase Price Per Share or the Alternative Purchase Price Per Share, as the case may be (including, without limitation,
the selection of an appraiser in calculating the Alternative Purchase Price Per Share). 
  
 6. Additional Shareholders. No Person (other than the parties to this Agreement) shall become an Additional Shareholder unless it shall execute and deliver to the Company a written agreement, in
substantially the form of Exhibit 1 hereto, agreeing to be bound by all of the terms and conditions of this Agreement as if it were a Shareholder. In no event, however, shall such Additional Shareholder be entitled to the first refusal rights
provided in Section 4 hereof or the preemptive rights provided in Section 9 hereof unless the written consent of the Shareholders and Approved Shareholders holding more than 75% in interest of the Shares held by all of the Shareholders and Approved
Shareholders is first obtained. 
  
 7. Sales
Transactions. (a) In the event that, notwithstanding any action or inaction whatsoever by the Board, Shareholders and Permitted Transferees (other than Permitted Transferees pursuant to Section 1.22(v), (vi) or (vii) hereof) beneficially
owning at least 51% of the Total Shares Outstanding held by such Shareholders and Permitted Transferees desire to engage in a Sales Transaction, such Shareholders and Permitted Transferees (the “Triggering Shareholders”) may submit a
notice (the “Sales Transaction Notice”) to the Board. The Sales Transaction Notice shall state a price (the “Sales Price”) which the Triggering Shareholders have in good faith determined to be the price at which they are willing
to sell the Company. 
  
 (b) Promptly after receipt of any such
Sales Transaction Notice, the Board shall determine whether the Sales Price set forth in such Sales Transaction Notice exceeds the Total Company Valuation as of the date of such Sales Transaction Notice. If such Sales Price is equal to or greater
than the Total Company Valuation as determined by the Board as of the date of such Sales Transaction Notice, the Board shall upon such determination so notify the Triggering Shareholders and the Board shall use all reasonable efforts (including
engaging a qualified investment banking firm, designated by the Triggering Shareholders, provided that the choice of such investment banking firm and the terms of such engagement are subject to the approval of the Board, which approval shall not be
unreasonably withheld) to enter into a binding agreement with respect to a Sales Transaction with any Person within 150 days thereafter; provided, however, that the purchase price of the Company in any such Sales Transaction shall be
equal to at least 98% of the Sales Price and must be fully payable in cash. 
  

 13 

 In the event the Board cannot close such a Sales Transaction with any Person within such 150-day period at a price equal
to or greater than 98% of the Sales Price, the Triggering Shareholders owning a majority of the Shares held by such Triggering Shareholders may elect to proceed toward a Sales Transaction with a Person who has submitted a bona fide offer (including
evidence of adequate financing) to the Company for a Sales Transaction at a price less than 98% of the Sales Price or at a price consisting of consideration other than cash (an “Alternative Sales Transaction”); provided,
that, the purchase price of any such Sales Transaction or Alternative Sales Transaction consummated by the Triggering Shareholders shall not be less than the Total Company Valuation as previously determined by the Board pursuant to such Sales
Transaction Notice and that if such purchase price in an Alternative Sales Transaction includes securities or other property, the Board will determine in good faith the value thereof (any such determination of the value of such securities or other
property by the Board in accordance with the advice of its investment banker being presumptively deemed to be a determination made in good faith). 
  
 (c) In the event that the Sales Price set forth in any such Sales Transaction Notice is less than the Total Company Valuation as determined by the Board
as of the date of such Sales Transaction Notice, the Board shall immediately upon such determination provide the Non-Triggering Shareholders with a copy of such Sales Transaction Notice. A majority of the Non-Triggering Shareholders (the
“Non-Triggering Shareholders’ Representatives”) shall have the power and authority to act on behalf of all of the Non-Triggering Shareholders. For a period of 150 days thereafter, the Non-Triggering Shareholders’ Representatives
or an entity designated by them (any such entity being referred to as a “Non-Triggering Person”) shall have the right to purchase the Company for cash at the Sales Price; provided, however, that, unless on or before the
90th day of such 150-day period the Non-Triggering Shareholders’ Representatives (or the Non-Triggering Person,
as the case may be) shall have demonstrated to the reasonable satisfaction of the Board financing commitments adequate to finance the Sales Price, such right shall lapse. 
  
 (d) In the event the Non-Triggering Shareholders’ Representatives (or the Non-Triggering Person, as the case may be)
elect not to exercise their right to purchase the Company on the terms set forth in any Sales Transaction Notice contemplated in (c) above, such right lapses in accordance with the foregoing or the closing of such a transaction does not occur within
the allotted 150-day period, the Triggering Shareholders may for a period of 15 days elect to withdraw their request for a Sales Transaction. If such withdrawal does not occur, the Board shall use all reasonable efforts (including engaging a
qualified investment banking firm, designated by the Triggering Shareholders, provided that the choice of such investment banking firm and the terms of such engagement are subject to the approval of the Board, which approval shall not be
unreasonably withheld) to enter into a binding agreement with respect to a Sales Transaction with any Person within 150 days thereafter; provided, however, that the purchase price of the Company in any such Sales Transaction shall be
equal to at least 98% of the Sales Price and must be fully payable in cash. 
  
 (e) In the event the Board cannot close a Sales Transaction with any Person within the 150-day period at a price equal to or greater than 98% of the Sales Price as provided in (d) above, the Triggering Shareholders
owning a majority of the Shares held by such Triggering Shareholders may elect to proceed toward a Sales Transaction with a Person who has submitted a bona fide offer (including evidence of adequate financing) to the Company for a 
  

 14 

 Sales Transaction or an Alternative Sales Transaction at a price less than 98% of such Sales Price; provided,
however, that the Non-Triggering Shareholders’ Representatives (or the Non-Triggering Person, as the case may be) shall have 90 days from the election of the Triggering Shareholders to proceed with such Alternative Sales Transaction to
provide evidence that they have adequate financing to match the terms of such Alternative Sales Transaction, and 60 days thereafter to close a Sales Transaction on the same terms as the Alternative Sales Transaction. In the event the Non-Triggering
Shareholders’ Representatives (or the Non-Triggering Person, as the case may be) choose not to purchase the Company on the terms of the Alternative Sales Transaction or the closing of such a transaction does not occur within the allotted
150-day period, the Board shall use all reasonable efforts to close the Alternative Sales Transaction within 150 days thereafter. If the purchase price in an Alternative Sales Transaction includes securities or other property, the Board will
determine in good faith the value thereof (any such determination of the value of such securities or other property by the Board in accordance with the advice of its investment banker being presumptively deemed to be a determination made in good
faith); provided that in any Alternative Sales Transaction in which the Non-Triggering Shareholders’ Representatives (or the Non-Triggering Person, as the case may be) are exercising the right to purchase any such determination of value of any
securities or property must be in accordance with the advice of an investment banker or valuation firm of recognized national standing designated by the Board. 
  

(f) In the event the Non-Triggering Shareholders choose to purchase the Company in a Sales Transaction or Alternative Sales Transaction as set forth
above, the Non-Triggering Shareholders may elect, in lieu of such Sales Transaction or Alternative Sales Transaction, to have the Company redeem all (but not less than all) of the Shares held by Triggering Shareholders at a price per Share
equivalent to the price set in such Sales Transaction or Alternative Sales Transaction. 
  
 If the Triggering Shareholders submit a Sales Transaction Notice to the Board pursuant to this Section 7 and no such Sales Transaction or Alternative Sales Transaction is consummated, Shareholders and Permitted
Transferees comprising a majority of such Triggering Shareholders are prohibited from participating in a request for a second Sales Transaction for a period of one year from the termination of the most recent efforts to cause a Sales Transaction or
Alternative Sales Transaction. Any provision of this Section 7 may be changed or modified, and any obligation or restriction of any party hereunder may be waived, only with the consent of the Board of the Company and the Shareholders and their
Permitted Transferees holding more than 75% in interest of the Shares held by Shareholders and their Permitted Transferees which are subject to this Agreement; provided that, if a Sales Transaction Notice has been given, any changes, waiver or
modification affecting a Sales Transaction or Alternative Sales Transaction resulting therefrom shall also require the consent of the Non-Triggering Shareholders holding a majority of the Shares held by the Non-Triggering Shareholders with respect
to such Transaction Notice. 
  
 8. Sale of the
Company. 
  
 (a) In connection with any sale of the
Company pursuant to Section 7 hereof, each Shareholder and Additional Shareholder that is selling Shares in such transaction shall receive the same proportion of each type of consideration received or to be received by all of the 
  

 15 

 Shareholders and Additional Shareholders in the aggregate; provided, however, that if the Non-Triggering
Shareholders or the Non-Triggering Person purchase the Company, such Persons may designate that some or all of the consideration allocable to their Shares if credited toward the Sales Price. 
  
 (b) In connection with any sale of the Company pursuant to Section 7 hereof,
each Shareholder and Additional Shareholder hereby agrees that such sale may take the form of a sale of all but not less than all of the Shares (in addition to a merger, consolidation or sale of assets), provided, that the Company may not cause such
sale to take such form, without the consent of such Shareholder or Additional Shareholder if the taking of such form would materially increase the aggregate tax liability payable in connection with such sale over the liability that would be payable
in connection with a merger, consolidation or sale of assets, and each seller: 
  
 (i) constitutes and appoints the Triggering Shareholders as such Person’s true and lawful agents and attorneys-in-fact, with full
power and authority in such Person’s name, place and stead to execute (A) any agreement containing the terms of such a sale of stock in accordance with the foregoing, such representations and warranties involving the due authorization,
execution, delivery and binding nature as regard such Person of such agreement and the nature of such Person’s title to its Shares as such agents and attorneys-in-fact may deem to be customary and reasonable (provided that no representation or
warranty other than as to due authorization, execution, title, delivery and the binding nature of such agreement and as to the good and marketable title of the Shares shall survive the closing of such Sales Transaction), and such other terms and
provisions binding on such Persons as may be necessary to consummate such transaction, (B) such instruments of conveyance and assignment as may be customary and necessary to consummate such transaction and (C) such receipts and related instruments
as may be necessary to evidence such consummation; 
  
 (ii) authorizes such agents and attorneys-in-fact to deduct or cause to be deducted, or to pay on such Person’s behalf, such Person’s pro rata (based on the number of Shares to be sold by each seller to the total number of Shares
to be sold in the Sales Transaction) share of any fees or expenses relating to such transaction, including, without limitation, fees and expenses of counsel and advisors to the Company; 
  
 (iii) agrees to deliver to such agents and attorneys-in-fact or their designee, acting as a custodian, at or
prior to the completion of such transaction, certificates representing all of the Shares to be sold by it, which certificates shall be free of all liens, encumbrances and endorsements and shall be duly endorsed in blank or in the name of the
purchaser thereof; and 
  
 (iv) agrees to sell
such Person’s Shares on such terms notwithstanding that such Person withholds consent or approval to such sale, gives any notice to such agents and attorneys-in-fact or any other Person of any nature or takes any other action inconsistent with
such sale. 
  

 16 

 (c) Prior to the consummation of any such sale pursuant to the terms hereof, if a vote or consent of the
Board or of shareholders of the Company is required under the Company’s Articles of Incorporation or applicable state law, the Board will convene a meeting at which all Directors will vote in favor of such transaction and/or will call a special
meeting of all shareholders of the Company at which each Shareholder and Additional Shareholder agrees to vote all of its Shares in favor of such transaction, as the case may be. 
  
 9. Preemptive Rights. Each Shareholder, Permitted Transferee and Approved Shareholder shall have preemptive
rights to purchase such number of Shares as shall be required to maintain their proportionate equity interest in the Company upon the future issuance of shares of Common Stock of any class, whether with or without voting privileges, under the same
terms and conditions and for the same consideration as such shares are offered or sold to any other Person. Each Shareholder, Permitted Transferee and Approved Shareholder shall also have preemptive rights to purchase, upon the future issuance of
any securities of the Company (including, without limitation, preferred stock, warrants, options or contracts (other than warrants, options or contracts issued to or entered into with employees or directors of the Company, or any subsidiary or
Affiliate thereof who were not shareholders of the Company on the date of this Agreement), or contracts exercisable for or convertible into common stock of any class) as shall be required to maintain their proportionate equity interest in the
Company, upon the same terms and for the same consideration as such securities are sold to any other Person. The preemptive rights established pursuant to this Section 9 shall not apply to (i) any issuance of Shares or other securities issued in
connection with the acquisition of stock or assets of any Person not affiliated with any Shareholder, (ii) any Shares issued upon the exercise of stock options granted to employees of the Company or pursuant to employee benefit plans so long as the
number of Shares so issued shall not exceed 8% of the Total Shares Outstanding on a fully diluted basis (as adjusted for any stock split or other similar recapitalization) or (iii) the sale of any Shares which had previously been issued (or
securities exercisable for or convertible into such Shares). Such preemptive rights shall expire at such time as a registration statement for a Public Offering becomes effective. 
  
 10. Right of Co-Sale. Except for Transfers to Permitted Transferees, no Shareholder or group of three or fewer
Shareholders owning more than 10% of the Total Shares Outstanding, whether such Shareholder is acting alone or in concert with any others pursuant to a common plan, understanding or arrangement, may agree or contract to Transfer, arrange for the
Transfer of or Transfer to any Person or group of Persons, directly or indirectly or through one or more intermediaries, any shares of common stock or any other equity securities of the Company (including, without limitation, warrants, options,
contracts or convertible securities permitting the holder thereof to acquire any such shares upon exercise or conversion thereof), unless: 
  
 (a) The number of such Shares subject to such agreement, contract, arrangement or Transfer, when taken together with (i) the number of
shares of all other such equity securities (which, in the case of any such warrants, options, contracts or convertible securities, shall be deemed to be the aggregate number of such shares which could be so acquired upon such exercise, whether or
not such exercise may be effected presently) and (ii) all other shares subject to any such agreement, contract, arrangement or Transfer effected or entered into in connection therewith or as part of such common plan, understanding or 
  

 17 

 arrangement, is less than 5% of the total number of Shares issued and outstanding at the time such
agreement, contract or arrangement is entered into and at the time such sale is consummated; or 
  
 (b) Effective provision is made whereby each Shareholder, Permitted Transferee and Additional Shareholder is given the opportunity to sell
any portion or all of its Shares concurrently with the aforementioned sale to any such Person or group on terms (including, without limitation, the form and amount of, and the time of receipt of, consideration therefor) identical to those applicable
to such aforementioned sale; or 
  
 (c) A
registration statement for a Public Offering has become effective or such transaction is part of such Public Offering. 
  
 No opportunity shall be deemed given to any Shareholder, Permitted Transferee and Additional Shareholder for purposes of Section 10(b) above unless (i)
each Shareholder or Permitted Transferee shall have been given written notice, setting forth in detail the terms of such proposed agreement, contract, arrangement or sale, and shall have been given at least 15 days after such notice is given within
which to exercise its rights contained in Section 10(b) by written notice thereof given to the selling shareholder, (ii) the terms on which such selling shareholder actually sells his Shares or equity securities are no more favorable to such
Shareholder than the terms set forth in the notice given by it pursuant to clause (i) of this sentence, and (iii) the Person or group to which such selling shareholder actually sells his Shares or equity securities actually purchases, at or prior to
the time of purchase of such Shares, from each Shareholder, Permitted Transferee and Additional Shareholder exercising his or its rights pursuant hereto at least such number of Shares as such holder shall specify in the notice given by such holder
pursuant to clause (i) of this sentence. 
  
 11.
Registration Rights. If the Company at any time during the effectiveness of this Agreement grants registration rights to any Person, the Company shall grant substantially the same registration rights to all Shareholders and Permitted
Transferees; provided, however, that the Company may grant registration rights (i) in connection with the acquisition of stock or assets of any Person not affiliated with any Shareholder or (ii) to a lender in connection with a financing
transaction, in each case without having to grant registration rights to any Shareholder or Permitted Transferee. 
  
 12. Pledge of Shares. If requested by the Board and approved by the Shareholders and Permitted Transferees holding a majority of Shares held
by all of the Shareholders and Permitted Transferees, the Company may require the Shareholders and Additional Shareholders to pledge their Shares to secure indebtedness or obligations of the Company or its subsidiaries. Subject to applicable laws
and regulations, each Shareholder and Additional Shareholder is obligated to execute and deliver such pledge agreements, consents, financing statements or other certificates, instruments, agreements, notices or other documents as the Board, in its
sole discretion, may deem necessary or advisable in connection therewith. In the event such a pledge of Shares occurs and the pledgee forecloses upon a pledge by a Shareholder or Additional Shareholder in a manner disproportionate to that of any
other Shareholders or Additional Shareholders (except for events in which such Shareholder or Additional Shareholder is in default of a covenant under its pledge agreement other than through 
  

 18 

 an act or omission of the Company), all Shareholders and Additional Shareholders shall contribute portions of their
remaining Shares in order to make such foreclosure proportionate among all Shareholders and Additional Shareholders; provided, however, that any proceeds obtained by such Shareholder or Additional Shareholder from such a foreclosure
shall be distributed among such Shareholder and all other Shareholders and Additional Shareholders making such a contribution in the proportion to the Shares held by them after such contribution. 
  
 13. Restrictions on Options. The Company, during the
effectiveness of this Agreement, shall not grant stock options to any Persons other than employees of the Company. 
  
 14. Legend. All Shareholders and Additional Shareholders agree that any certificates evidencing Shares subject to this Agreement shall be
stamped or endorsed with a legend in substantially the following form; provided, however, that in the event that Shares are registered under the Act the Company shall promptly upon request, but in any event not later than the execution
of an underwriting agreement or sales agency agreement relating thereto, deliver a replacement certificate not containing the first sentence of the legend below in exchange for the legended certificate (it being understood that such legend shall be
placed on such replacement certificate if the sale does not occur in accordance with the terms of the registration statement); and provided further, that the Company shall upon termination of this Agreement promptly upon request
deliver a replacement certificate not containing the last four sentences of the legend below in exchange for the legended certificate: 
  
 THE SHARES OF COMMON STOCK REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAW,
IF ANY, AND NEITHER THE SHARES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACT OR LAW AND THE RULES AND REGULATIONS THEREUNDER. BY ITS
ACCEPTANCE HEREOF, THE HOLDER OF THIS CERTIFICATE REPRESENTS THAT IT IS ACQUIRING THESE SHARES FOR INVESTMENT. 
  
 THE SHARES OF COMMON STOCK REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AMENDED AND RESTATED SHAREHOLDERS AGREEMENT DATED AS OF JULY 15, 2004 (AS IT MAY BE
AMENDED FROM TIME TO TIME, THE “AGREEMENT”) AMONG THE COMPANY AND CERTAIN OF ITS EQUITY HOLDERS. NO TRANSFER OF SUCH SHARES OF COMMON STOCK OR THIS CERTIFICATE MAY BE MADE EXCEPT IN ACCORDANCE WITH THE AGREEMENT. A COPY OF THE AGREEMENT IS
ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND MAY BE OBTAINED WITHOUT CHARGE UPON WRITTEN REQUEST TO THE COMPANY. 
  
 15. Term. This Agreement shall be effective as of the date hereof and shall terminate as follows: (a) except as otherwise specified therein,
the provisions of Sections 2 (except for the last sentence of Section 2(a)), 4, 5, 7, 12 and 13 hereof shall terminate upon the first to occur of September 30, 2007 and the effectiveness of a registration statement for a Public Offering; (b) the
provisions of Section 11 hereof shall terminate two years after the date of the 
  

 19 

 effectiveness of a registration statement for a Public Offering and (c) the remaining provisions shall terminate upon the
effectiveness of a registration statement for a Public Offering; provided that any such provisions terminated as a result of the effectiveness of a registration statement for a Public Offering shall be reinstated if such Public Offering is not
consummated. 
  
 16. Dispositions in Violation of
Agreement. No Shareholder or Additional Shareholder shall make any Transfer in violation of this Agreement. If any disposition of Shares is made or attempted to be made contrary to the provisions of this Agreement, in addition to any other
legal or equitable remedies which it may have, the Company may refuse to recognize any transferee as one of the Company’s Additional Shareholders for any purpose including, without limitation, distribution and voting rights, until all
applicable provisions of this Agreement have been complied with. 
  
 17. Specific Performance. The parties agree that it is impossible to measure in money the damages which will accrue to a party by reason of a failure to perform any of the obligations set forth in this Agreement. Therefore, if
any party shall institute any action or proceeding to enforce the terms of this Agreement or alleging a breach of any of the provisions of this Agreement, in addition to any other remedy available at law, such party may seek specific performance of
the terms hereof; and any other party against whom such action or proceeding is brought hereby waives the claim or defense that a remedy at law alone is adequate, and agrees (to the maximum extent permitted by law) to have such provision
specifically enforced against him by any court of equity, without the necessity of posting bond or other security against him, and consents to the entry of injunctive relief against him enjoining or restraining any violation or threatened violation
of this Agreement. 
  
 18. Notices. Notices of any
other communication provided for in this Agreement shall be given in writing and shall be hand-delivered or mailed by registered or certified mail, in the case of the Company, to: Da-Lite Screen Company, Inc., 3100 North Detroit, Warsaw, Indiana
46580, Attention: Chairman and President (or such other address as the Company may designate in a written notice to each other party to this Agreement), in the case of any Shareholder, to his address as listed on Schedule I to this Agreement, or to
any other address as he (or his Permitted Transferee) may designate in a written notice to the Company with a copy to each other party to this Agreement and, in the case of Additional Shareholders, to a representative from time to time so designated
by a majority of the Additional Shareholders. All notices mailed pursuant to this Section 18 shall be presumed received five days after the date of mailing. 
  
 19. Modification and Waiver. Except as otherwise provided in this Agreement, any provision of this Agreement can be changed or modified, and
any obligation or restriction of any party hereunder can be waived only with the consent of the Company and the Shareholders and Additional Shareholders holding more than 66 2/3% in interest of all of the issued and outstanding Shares subject to this Agreement. 
  
 20. Binding Agreement. This Agreement shall be binding upon the parties hereto and to the extent provided
herein shall inure to the benefit of their respective legal representatives, heirs, executors, administrators, successors and assigns. 
  

 20 

 21. Counterparts. This Agreement may be executed in two or more counterparts, all of which
together shall constitute one and the same instrument. This Agreement will not be deemed effective until all parties have executed a counterpart of this Agreement. 
  
 22. Partial Invalidity. Wherever possible, each provision hereof shall be interpreted in such manner as to be
effective and valid under applicable law, but in case any one or more of the provisions contained herein shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such provision shall be deemed modified to the extent,
but only to the extent, of such invalidity, illegality or unenforceability without invalidating the remainder of such invalid, illegal or unenforceable provision or provisions, unless such a construction would be unreasonable. It is the intent and
understanding of each party hereto that if, in any action before any court or agency legally empowered to enforce the provisions of this Agreement, any provision of this Agreement is found to be unreasonable and for that reason unenforceable, then
such provision shall be deemed modified to the extent necessary to make it enforceable by such court or agency. No determination by any such court or agency that a specific party’s obligations hereunder are unenforceable in whole or in part
hereunder shall in any respect be construed to impair or otherwise affect any obligations of any other party hereunder. 
  
 23. Assignments. No Shareholder or Additional Shareholder may assign any of his or her rights hereunder without the prior written consent of
the Company or the holders of more than 66 2/3% in interest of all of the Shares subject to this Agreement; the
Company may at any time assign its rights hereunder to any Person, including specifically, without limitation, the Company’s right to purchase Shares pursuant to the provisions of Section 4 hereof. 
  
 24. Entire Agreement. This Agreement is intended by the parties
as a final expression of their agreement and is intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein. 
  
 25. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF INDIANA APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED WHOLLY WITHIN THE STATE OF INDIANA. 
  

 21 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

  

			
	 DA-LITE SCREEN COMPANY, INC.

		
	 By:
	 	 /s/ Richard E. Lundin

	 Name:
	 	 Richard E. Lundin

	 Title:
	 	 Chairman, President and Chief
 Executive Officer

  

 22 

 Exhibit 1 
  
 In consideration of the transfer by Da-Lite Screen Company, Inc. (the “Company”) of shares of its common stock to the undersigned, the
undersigned, having all due authority, hereby agrees to be bound by the terms and provisions of the Shareholders Agreement, dated as of July 15, 2004 (as it may be amended from time to time), by and among the Company and the persons listed on the
signature pages thereto. 
  

 23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]